raloxifene hydrochloride has been researched along with Fibrosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Concors, SJ; Ge, G; Hancock, WW; Hernandez, P; Levine, MH; O'Brien, C; Wang, Z | 1 |
| Ju, JH; Kim, Y; Nam, Y; Rim, YA | 1 |
| Aguado, T; Botella, LM; Del Río, M; Ferrer-Mayorga, G; García, A; García, M; Martínez-Santamaría, L; Sánchez-Puelles, JM | 1 |
| Bernárdez, C; Castellanos-González, M; Fernández-Crehuet, P; Fernández-Pugnaire, MA; Grimalt, R; Hermosa-Gelbard, A; Molina-Ruiz, AM; Moreno-Arrones, OM; Ormaechea-Pérez, N; Rodrigues-Barata, AR; Saceda-Corralo, D; Vaño-Galván, S | 1 |
| Chang, CC; Chang, T; Chuang, CL; Hsin, IF; Hsu, SJ; Huang, HC; Lee, FY; Lee, SD; Lee, WS | 1 |
| Fliegner, D; Penkalla, A; Petrov, G; Prelle, K; Regitz-Zagrosek, V; Schubert, C; Westphal, C | 1 |
| Ihoriya, C; Kadoya, H; Kashihara, N; Kidokoro, K; Nagasu, H; Nishi, Y; Sasaki, T; Satoh, M | 1 |
7 other study(ies) available for raloxifene hydrochloride and Fibrosis
| Article | Year |
|---|---|
The Selective Estrogen Receptor Modulator, Raloxifene, Is Protective Against Renal Ischemia-reperfusion Injury.
Topics: Acute Kidney Injury; Animals; Creatinine; Dimethyl Sulfoxide; Estrogens; Female; Fibrosis; Kidney; Mice; Mice, Inbred C57BL; Raloxifene Hydrochloride; Reperfusion Injury; Selective Estrogen Receptor Modulators | 2022 |
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis.
Topics: Animals; Cells, Cultured; Fibroblasts; Fibrosis; Humans; Leukocytes, Mononuclear; Mice; Raloxifene Hydrochloride; Scleroderma, Systemic; Selective Estrogen Receptor Modulators; Skin; Skin Diseases | 2022 |
Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa.
Topics: Acetylcysteine; Activin Receptors, Type II; Antioxidants; Case-Control Studies; Collagen Type VII; Drug Repositioning; Endoglin; Epidermolysis Bullosa; Estrogen Antagonists; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Inheritance Patterns; Primary Cell Culture; Raloxifene Hydrochloride; Receptor, Transforming Growth Factor-beta Type I; Severity of Illness Index; Signal Transduction; Skin; Smad Proteins; Transforming Growth Factor beta1 | 2020 |
Risk factors associated with frontal fibrosing alopecia: a multicentre case-control study.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Case-Control Studies; Comorbidity; Estrogen Antagonists; Female; Fibrosis; Forehead; Hormone Replacement Therapy; Humans; Lichen Planus; Male; Middle Aged; Occupational Exposure; Raloxifene Hydrochloride; Risk Factors; Sunscreening Agents | 2019 |
Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.
Topics: Ammonia; Animals; Body Weight; Female; Fibrosis; Gene Expression Regulation; Hemodynamics; Hepatic Encephalopathy; Hypertension, Portal; Liver; Liver Cirrhosis; Motor Activity; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2017 |
Effects of estrogen, an ERα agonist and raloxifene on pressure overload induced cardiac hypertrophy.
Topics: Animals; Aorta; Biomarkers; Cardiomegaly; Constriction, Pathologic; Disease Progression; Estrogen Receptor alpha; Estrogens; Extracellular Matrix Proteins; Female; Fibrosis; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Organ Size; Pressure; Raloxifene Hydrochloride; Survival Analysis; Systole; Ultrasonography; Uterus; Ventricular Function, Left | 2012 |
Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status.
Topics: Animals; Apoptosis; Atrophy; Cells, Cultured; Cytokines; Disease Models, Animal; Female; Fibrosis; Gene Expression Regulation; Glomerulonephritis; Humans; Inflammasomes; Inflammation Mediators; Kidney Tubules, Proximal; Lipid Peroxidation; Macrophages; Mice; Mice, Inbred ICR; Mitochondria; Nephritis, Hereditary; NF-kappa B; Ovariectomy; Oxidation-Reduction; Oxidative Stress; Proteinuria; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2013 |